Aurobindo Pharma said the product has an estimated market size of $138 million for the 12 months ending February 2026. Shares of Aurobindo Pharma Ltd ended at ₹1,384.45, down by ₹1.65, or 0.12%, on the BSE today, April 17.
Aurobindo Pharma said the product has an estimated market size of $138 million for the 12 months ending February 2026. Shares of Aurobindo Pharma Ltd ended at ₹1,384.45, down by ₹1.65, or 0.12%, on the BSE today, April 17.